Title | Date | Type | Setname | ||
---|---|---|---|---|---|
1 | Orally Administered SIRTl Activator SRT501 is Neuroprotective for Retinal Ganglion Cells and Suppresses Neurological Dysfunction in a Mouse Model of Multiple Sclerosis | 2008-03-10 | Text | ehsl_novel_nam | |
2 | Retinal Ganglion Cell Loss in a Mouse Model of Optic Neuritis | 2005-02-15 | Text | ehsl_novel_nam | |
3 | Sirtuin-Activating Compounds Prevent Retinal Ganglion Cell Loss During Acute Optic Neuritis | 2006-02-27 | Text | ehsl_novel_nam | |
4 | Utah Center of Excellence ELSI Research (UCEER) - Art Document | 2014 | ehsl_gapp | ||
5 | Utah Center of Excellence ELSI Research (UCEER) - Design Document | 2014 | ehsl_gapp | ||
6 | Utah Center of Excellence ELSI Research (UCEER) - Project Schedule | 2014 | ehsl_gapp | ||
7 | Utah Center of Excellence ELSI Research (UCEER) - Style Guide | 2014 | ehsl_gapp |